Clinical Trial: Study of AT-02 in Healthy Volunteers and Subjects With Systemic Amyloidosis
Study Status: Completed
Recruit Status: RECRUITING
Condition: Amyloidosis; Systemic
Study Type: INTERVENTIONAL
Official Title: A Three-part, Phase 1, Single-ascending, and Multiple-ascending Dose Escalation Study in Healthy Volunteers and Subjects With Systemic Amyloidosis to Assess the Safety, Tolerability, and Pharmacokinet
Brief Summary:
This is a multicenter, international, three-part, Phase 1 study designed to evaluate the safety, tolerability, and PK of rising single doses of AT-02 in healthy volunteers and in subjects with systemic amyloidosis and to assess the safety, tolerability, and PK of multiple doses of AT-02 in subjects with systemic amyloidosis.
Read more